BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 3763091)

  • 1. Transient vasopressin-resistant diabetes insipidus of pregnancy.
    Ford SM; Lumpkin HL
    Obstet Gynecol; 1986 Nov; 68(5):726-8. PubMed ID: 3763091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient vasopressin-resistant diabetes insipidus of pregnancy.
    Ford SM
    Obstet Gynecol; 1986 Aug; 68(2):288-9. PubMed ID: 3737046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics of 7 patients with gestational diabetes insipidus].
    Wu LQ; Xiong CQ; Wu M; Dong RL; Chen YQ; Gao J; Chen OJ; Huang YP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):266-8. PubMed ID: 18843966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent diabetes insipidus associated with pregnancy: pathophysiology and therapy.
    Hughes JM; Barron WM; Vance ML
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):462-4. PubMed ID: 2915875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transient polyuria in pregnancy in diabetes insipidus and gestational diabetes].
    Hensen J; Dolz M; Oelkers W
    Med Klin (Munich); 1991 Dec; 86(12):623-8. PubMed ID: 1770904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient gestational diabetes insipidus: report of two cases and review of pathophysiology and treatment.
    El-Hennawy AS; Bassi T; Koradia N; Bocirnea A
    J Matern Fetal Neonatal Med; 2003 Nov; 14(5):349-52. PubMed ID: 14986811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggravation of subclinical diabetes insipidus during pregnancy.
    Iwasaki Y; Oiso Y; Kondo K; Takagi S; Takatsuki K; Hasegawa H; Ishikawa K; Fujimura Y; Kazeto S; Tomita A
    N Engl J Med; 1991 Feb; 324(8):522-6. PubMed ID: 1992305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide secretion was not directly affected by arginine vasopressin in diabetes insipidus.
    Shimizu H; Tanaka Y; Nakamura K; Uehara Y; Shimomura Y
    J Med; 1991; 22(4-5):299-305. PubMed ID: 1838565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnant woman with transient diabetes insipidus resistant to 1-desamino-8-D-arginine vasopressin.
    Jin-no Y; Kamiya Y; Okada M; Watanabe O; Ogasawara M; Fujinami T
    Endocr J; 1998 Oct; 45(5):693-6. PubMed ID: 10395251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient postpartum diabetes insipidus in twin pregnancy associated with HELLP syndrome.
    Yamanaka Y; Takeuchi K; Konda E; Samoto T; Satou A; Mizudori M; Maruo T
    J Perinat Med; 2002; 30(3):273-5. PubMed ID: 12122912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes insipidus in the third trimester of pregnancy.
    Brewster UC; Hayslett JP
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1173-6. PubMed ID: 15863571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of vasopressin analogue DDAVP in patients with postoperative diabetes insipidus (author's transl)].
    Kubota T; Kashiwara K; Ito H; Tani K; Yamamoto S
    No To Shinkei; 1981 Jun; 33(3):617-23. PubMed ID: 7259900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
    Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient diabetes insipidus of pregnancy.
    Krege J; Katz VL; Bowes WA
    Obstet Gynecol Surv; 1989 Nov; 44(11):789-95. PubMed ID: 2677861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
    Coculescu M; Antipa C; Cucu C
    Endocrinologie; 1977; 15(4):275-81. PubMed ID: 563614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of diabetes insipidus with a synthetic analog of vasopressin during pregnancy.
    Sack J; Friedman E; Katznelson D; Frenkel Y
    Isr J Med Sci; 1980 May; 16(5):406-7. PubMed ID: 7399872
    [No Abstract]   [Full Text] [Related]  

  • 20. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.
    Moses AM; Scheinman SJ; Oppenheim A
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1044-9. PubMed ID: 6490792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.